These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


151 related items for PubMed ID: 4055057

  • 1. Cefotaxime monotherapy of bacterial meningitis caused by gram-positive pathogens.
    Helwig HF.
    Infection; 1985; 13 Suppl 1():S62-7. PubMed ID: 4055057
    [Abstract] [Full Text] [Related]

  • 2. [Analysis of pathogenic bacteria and drug resistance in neonatal purulent meningitis].
    Zhu M, Hu Q, Mai J, Lin Z.
    Zhonghua Er Ke Za Zhi; 2015 Jan; 53(1):51-6. PubMed ID: 25748405
    [Abstract] [Full Text] [Related]

  • 3. Cefotaxime in the treatment of meningitis.
    Cherubin CE, LeFrock J.
    Infection; 1985 Jan; 13 Suppl 1():S68-72. PubMed ID: 4055058
    [Abstract] [Full Text] [Related]

  • 4. Cefotaxime therapy of bacterial meningitis in children.
    Wells TG, Trang JM, Brown AL, Marmer BC, Jacobs RF.
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():181-9. PubMed ID: 6094438
    [Abstract] [Full Text] [Related]

  • 5. [Cefotaxime monotherapy in bacterial meningitis in childhood].
    Helwig H, Schlegel P.
    Monatsschr Kinderheilkd; 1986 Oct; 134(10):733-7. PubMed ID: 3796634
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and clinical evaluation of cefotaxime in children suffering with purulent meningitis.
    Bégué P, Floret D, Mallet E, Raynaud EJ, Safran C, Sarlangues J, Teyssier G.
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():161-5. PubMed ID: 6094436
    [Abstract] [Full Text] [Related]

  • 7. Treatment of 160 cases of acute bacterial meningitis with cefotaxime.
    Lecour H, Seara A, Miranda AM, Cordeiro J, Sarmento J.
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():195-202. PubMed ID: 6094440
    [Abstract] [Full Text] [Related]

  • 8. Treatment of gram-negative bacillary meningitis: role of the new cephalosporin antibiotics.
    Cherubin CE, Corrado ML, Nair SR, Gombert ME, Landesman S, Humbert G.
    Rev Infect Dis; 1982 Sep; 4 Suppl():S453-64. PubMed ID: 6294799
    [Abstract] [Full Text] [Related]

  • 9. Treatment of childhood bacterial meningitis.
    Lecour H, Seara A, Cordeiro J, Miranda M.
    Infection; 1989 Sep; 17(5):343-6. PubMed ID: 2689353
    [Abstract] [Full Text] [Related]

  • 10. A comparison of ampicillin-cefotaxime and ampicillin-chloramphenicol in childhood bacterial meningitis: an experience in 55 patients.
    Lapointe JR, Béliveau C, Chicoine L, Joncas JH.
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():167-80. PubMed ID: 6094437
    [Abstract] [Full Text] [Related]

  • 11. Serious bacterial infections in febrile infants younger than 90 days of age: the importance of ampicillin-resistant pathogens.
    Byington CL, Rittichier KK, Bassett KE, Castillo H, Glasgow TS, Daly J, Pavia AT.
    Pediatrics; 2003 May; 111(5 Pt 1):964-8. PubMed ID: 12728072
    [Abstract] [Full Text] [Related]

  • 12. [Value of cefotaxime in gram-negative bacterial meningitis. Apropos of 3 developmental forms in neonates and infants].
    Sarlangue J, Megraud F, Nelson JR, Martin C.
    Pediatrie; 1984 Dec; 39(8):645-51. PubMed ID: 6100207
    [Abstract] [Full Text] [Related]

  • 13. Experience with the use of cefotaxime in the treatment of bacterial meningitis.
    Cherubin CE, Eng RH.
    Am J Med; 1986 Mar; 80(3):398-404. PubMed ID: 3513559
    [Abstract] [Full Text] [Related]

  • 14. Clinical evaluation of the effect of cefotaxime in senile pneumonia caused by gram-positive and gram-negative bacteria.
    Katsunuma H.
    Infection; 1985 Mar; 13 Suppl 1():S18-24. PubMed ID: 4055049
    [Abstract] [Full Text] [Related]

  • 15. Clinical experience of cefotaxime in infections caused by gram-positive pathogens.
    Bassetti D, Solbiati M, Fraizzoli G.
    Infection; 1985 Mar; 13 Suppl 1():S112-4. PubMed ID: 4055040
    [Abstract] [Full Text] [Related]

  • 16. A prospective randomized comparison of cefotaxime vs ampicillin and chloramphenicol for bacterial meningitis in children.
    Jacobs RF, Wells TG, Steele RW, Yamauchi T.
    J Pediatr; 1985 Jul; 107(1):129-33. PubMed ID: 3847486
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of cefotaxime in gram-negative meningitis.
    LeFrock JL, Molavi A, Smith B, Black P, Rosenberg M, Rolston K, Brodner R, Chandrasekar P, Henao L, Kannangara DW.
    Neurosurgery; 1984 Nov; 15(5):679-82. PubMed ID: 6095133
    [Abstract] [Full Text] [Related]

  • 18. Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitis.
    Scheld WM, Rocha H, Sande MA, Bryan JP.
    Am J Med; 1984 Oct 19; 77(4C):42-9. PubMed ID: 6093518
    [Abstract] [Full Text] [Related]

  • 19. Intravenous cefotaxime in children with bacterial meningitis.
    Belohradsky BH, Bruch K, Geiss D, Kafetzis D, Marget W, Peters G.
    Lancet; 1980 Jan 12; 1(8159):61-3. PubMed ID: 6101414
    [Abstract] [Full Text] [Related]

  • 20. A review of the use of cefotaxime in the treatment of skin and skin structure infections, with special reference to gram-positive pathogens.
    Karakusis PH, Trenholme GM, Levin S.
    Infection; 1985 Jan 12; 13 Suppl 1():S46-9. PubMed ID: 4055055
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.